G protein-coupled receptor
κ-opioid receptor
Kappa opioid receptor
- GeneOPRK1
- FamilyOpioid receptors
- GroupOpioid receptors
The κ-opioid receptor was cloned from mouse brain together with the δ receptor, during a search for somatostatin receptors. Both couple to G proteins and inhibit the formation of cyclic AMP.1
Antibodies against the cloned receptor stained perikarya and fibres in the deep layers of the cortex, the central and medial amygdala, the bed nucleus of the stria terminalis, the nucleus accumbens, the olfactory tubercle, the claustrum, hypothalamic nuclei, the median eminence, the central gray, the dorsal raphe, the substantia nigra pars reticulata, the ventral tegmental area, the spinal cord and the dorsal root ganglia, and also the neural and intermediate lobes of the pituitary. The staining agreed well with earlier maps of the mRNA and of the binding. Kappa binding is less widespread than mu binding and was dense in the amygdala, olfactory tubercle, nucleus accumbens, caudate putamen, medial preoptic area, hypothalamus, median eminence, periventricular thalamus and interpeduncular nucleus.2,3
In mice lacking the receptor, the other components of the opioid system and the spontaneous activity are not changed, but the mice are more sensitive to chemical visceral pain. The hypolocomotor, analgesic and aversive actions of the kappa agonist U-50,488H depend on the receptor. It does not contribute to morphine analgesia and reward, but it takes part in the expression of morphine abstinence.4
The receptor activates pertussis toxin-sensitive Gi/o proteins, which inhibit adenylyl cyclase and release G beta-gamma, and G beta-gamma modulates calcium and potassium channels. Agonists also activate kinase cascades, among them GRKs and the MAP kinases ERK1/2, p38 and JNK. A review reports that ligand-induced conformations which evoke beta-arrestin-dependent p38 activation result in aversion, whereas conformations that activate JNK without arrestin produce a long-lasting inactivation of the receptor. The authors put forward that partial agonists which do not efficiently activate p38 may be analgesics without the dysphoric or hallucinogenic effects of highly efficacious agonists, and that antagonists which do not activate JNK may promote stress resilience.5
In men, the κ agonist MR 2033 caused dose-dependent dysphoria and psychotomimetic effects, and naloxone blocked them.6 In mice, repeated forced swim and inescapable footshock produced aversive behaviour that was blocked by a KOR antagonist and absent in mice lacking dynorphin. Injection of corticotropin-releasing factor or urocortin III produced place aversion that was blocked by deletion of the dynorphin gene or by KOR antagonism. The authors conclude that the aversive effects of stress are mediated by CRF2 receptor stimulation of dynorphin release and the subsequent activation of the KOR. Stress and CRF caused dynorphin-dependent KOR activation in the basolateral amygdala, the nucleus accumbens, the dorsal raphe and the hippocampus.7 Salvinorin A, the main active compound of Salvia divinorum, is a potent and selective agonist at this receptor. It showed no activity at 50 other receptors, transporters and ion channels, including the 5-HT2A receptor of the classic hallucinogens, and it is the first known natural agonist of an opioid receptor subtype without a nitrogen atom.8 In a double-blind study with four volunteers, the effects of inhaled salvinorin A peaked at the first measurement after two minutes and were gone after about 20 minutes.9
Sources (9)
- Yasuda et al. 1993Yasuda K, Raynor K, Kong H, et al. (1993) Cloning and functional comparison of kappa and delta opioid receptors from mouse brain Proc Natl Acad Sci U S A
- Mansour et al. 1996Mansour A, Burke S, Pavlic RJ, et al. (1996) Immunohistochemical localization of the cloned kappa 1 receptor in the rat CNS and pituitary Neuroscience
- Mansour et al. 1987Mansour A, Khachaturian H, Lewis ME, et al. (1987) Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain J Neurosci
- Simonin et al. 1998Simonin F, Valverde O, Smadja C, et al. (1998) Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal EMBO J
- Bruchas et al. 2010Bruchas MR, Chavkin C (2010) Kinase cascades and ligand-directed signaling at the kappa opioid receptor Psychopharmacology (Berl)
- Pfeiffer et al. 1986Pfeiffer A, Brantl V, Herz A, et al. (1986) Psychotomimesis mediated by kappa opiate receptors Science
- Land et al. 2008Land BB, Bruchas MR, Lemos JC, et al. (2008) The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system J Neurosci
- Roth et al. 2002Roth BL, Baner K, Westkaemper R, et al. (2002) Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist Proc Natl Acad Sci U S A
- Johnson et al. 2011Johnson MW, MacLean KA, Reissig CJ, et al. (2011) Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum Drug Alcohol Depend
Binding affinity (Kᵢ)
16 substances, 22 displayed values. Strongest first within each organism. The bar is pKᵢ on a log scale. Open a row to see the assay and every report behind the value.
Human
11 measurements
Buprenorphine0.11 nMHuang et al. 2001 · 3 reports
- Assay
- recombinant human KOR in CHO membranes, [3H]diprenorphine competition
- Shown value from
- Huang et al. 2001, Table 1
- Range
- 0.11–1.3 nM in 3 reports
- Error
- ± 0.05 SEM, n = 4
Values depend on the assay, species or conditions, and each is valid only for its own. 3 reports in all, 0.11–1.3 nM.
Sources and values behind the range, same assay family Report Value Where Huang et al. 2001 0.11 nM Table 1 Toll et al. 1998 0.80 nM Table 5 Obeng et al. 2021 1.3 nM Table 2 Hydromorphone2.8 nMWentland et al. 2009
- Assay
- CHO cell membranes expressing the human KOR, [3H]U69,593 displacement
- Shown value from
- Wentland et al. 2009, Table 1
Salvinorin A16 nMRoth et al. 2002 · 3 reports
- Assay
- HEK293 cells expressing cloned human KOR, [3H]bremazocine displacement
- Shown value from
- Roth et al. 2002, Table 1
- Range
- 1.3–19 nM in 3 reports
Reported values disagree and no value is established. 4 reports in all, 1.3–19 nM.
Sources and values behind the range, same assay family Report Value Where Roth et al. 2002 16 nM Table 1 Chavkin et al. 2004 19 nM Table 2 Béguin et al. 2005 1.3 nM Table 1 (text) Morphine24 nMNeumeyer et al. 2012 · 3 reports
- Assay
- CHO cells expressing human KOR, [3H]U69,593 competition
- Shown value from
- Neumeyer et al. 2012, Table 2
- Range
- 24–47 nM in 3 reports
- Error
- ± 2.3 SEM
Sources and values behind the range, same assay family Report Value Where Neumeyer et al. 2012 24 nM Table 2 Toll et al. 1998 47 nM Table 5 Obeng et al. 2021 40 nM Table 2 Fentanyl85 nMToll et al. 1998 · 2 reports
- Assay
- human KOR in CHO cells, [3H]U69,593 competition
- Shown value from
- Toll et al. 1998, Table 5
- Range
- 85–202 nM in 2 reports
- Error
- ± 19 SD
Sources and values behind the range, same assay family Report Value Where Toll et al. 1998 85 nM Table 5 Obeng et al. 2021 202 nM Table 2 7-Hydroxymitragynine188 nMKruegel et al. 2016 · 2 reports
- Assay
- cells expressing human KOR, opioid receptor binding
- Shown value from
- Kruegel et al. 2016, Table 2
- Range
- 188–220 nM in 2 reports
- Error
- ± 38 SEM
Sources and values behind the range, same assay family Report Value Where Obeng et al. 2021 220 nM Table 2 Kruegel et al. 2016 188 nM Table 2 Hydrocodone260 nMNeumeyer et al. 2012
- Assay
- CHO cells expressing human KOR, [3H]U69,593 competition
- Shown value from
- Neumeyer et al. 2012, Table 2
- Error
- ± 9.7 SEM
Methadone324 nMToll et al. 1998
- Assay
- human KOR in CHO cells, [3H]U69,593 competition
- Shown value from
- Toll et al. 1998, Table 5
- Error
- ± 18 SD
Mitragynine772 nMKruegel et al. 2016 · 2 reports
- Assay
- cells expressing human KOR, opioid receptor binding
- Shown value from
- Kruegel et al. 2016, Table 2
- Range
- 772–1700 nM in 2 reports
- Error
- ± 207 SEM
Sources and values behind the range, same assay family Report Value Where Obeng et al. 2021 1700 nM Table 2 Kruegel et al. 2016 772 nM Table 2 Psilocin2000 nMJain et al. 2025
- Assay
- radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
- Shown value from
- Jain et al. 2025, Table S4
Ibogaine3680 nMMaillet et al. 2015
- Assay
- cells expressing human kappa opioid receptor, radioligand binding
- Shown value from
- Maillet et al. 2015, Results
- Error
- ± 220 SEM
Guinea pig
6 measurements
Buprenorphine1.5 nMToll et al. 1998
- Assay
- guinea-pig brain membranes, [3H]U69,593 competition
- Shown value from
- Toll et al. 1998, Table 5
- Error
- ± 0.25 SD
Salvinorin A4.3 nMRoth et al. 2002
- Assay
- guinea pig brain membranes, [3H]bremazocine displacement (native KOR)
- Shown value from
- Roth et al. 2002, Table 1
Oxymorphone62 nMBen Haddou et al. 2014
- Assay
- native guinea pig brain membranes, [3H]U69,593 competition
- Shown value from
- Ben Haddou et al. 2014, Table 1
- Error
- ± 1.2 SEM
Morphine113 nMBen Haddou et al. 2014 · 2 reports
- Assay
- native guinea pig brain membranes, [3H]U69,593 competition
- Shown value from
- Ben Haddou et al. 2014, Table 1
- Range
- 34–113 nM in 2 reports
- Error
- ± 9.0 SEM
Reported values disagree and no value is established. 2 reports in all, 34–113 nM.
Sources and values behind the range, same assay family Report Value Where Ben Haddou et al. 2014 113 nM Table 1 Toll et al. 1998 34 nM Table 5 Fentanyl151 nMToll et al. 1998
- Assay
- guinea-pig brain membranes, [3H]U69,593 competition
- Shown value from
- Toll et al. 1998, Table 5
- Error
- ± 5.2 SD
Methadone728 nMToll et al. 1998
- Assay
- guinea-pig brain membranes, [3H]U69,593 competition
- Shown value from
- Toll et al. 1998, Table 5
- Error
- ± 120 SD
Rat
4 measurements
3-HO-PCP140 nMItzhak et al. 1981
- Assay
- rat brain homogenate (minus cerebellum), [3H]ethylketocyclazocine 1.5 nM, kappa site
- Shown value from
- Itzhak et al. 1981, Table 1B
Oxycodone677 nMMonory et al. 1999
- Assay
- rat brain membranes, displacement of [3H]U69,593
- Shown value from
- Monory et al. 1999, Table II
Tapentadol910 nMTzschentke et al. 2007
- Assay
- rat opioid receptor binding assay
- Shown value from
- Tzschentke et al. 2007, Table 1
- Error
- ± 90 SEM
PCP4100 nMItzhak et al. 1981
- Assay
- rat brain homogenate (minus cerebellum), [3H]ethylketocyclazocine 1.5 nM, kappa site
- Shown value from
- Itzhak et al. 1981, Table 1B
Unspecified
1 measurement
Mitragynine455 nMLydecker et al. 2016
- Assay
- KOR opioid receptor binding, quoted in a review table (original assay not restated)
- Shown value from
- Lydecker et al. 2016, Table 1
Functional potency (EC₅₀)
6 substances, 6 displayed values. Strongest first within each organism. Emax is shown where the paper reports it. Efficacy depends on the assay and its reference agonist.
Human
6 measurements
Buprenorphine0.04 nMHuang et al. 2001
- Assay
- recombinant human KOR in CHO membranes, [35S]GTPgammaS functional assay
- Shown value from
- Huang et al. 2001, Table 2
- Error
- ± 0.01 SEM
- Emax
- 10.0 ± 4.0%
Salvinorin A69 nMChavkin et al. 2004
- Assay
- Xenopus oocytes expressing KOR and Kir3.1/3.2, inward K+ current
- Shown value from
- Chavkin et al. 2004, Results, Fig. 4
Values depend on the assay, species or conditions, and each is valid only for its own. 3 reports in all, 0.63–69 nM.
Oxymorphone463 nMBen Haddou et al. 2014
- Assay
- CHO cells expressing human opioid receptor, [35S]GTPγS functional assay
- Shown value from
- Ben Haddou et al. 2014, Table 2
- Error
- ± 116 SEM
- Emax
- 48.0 ± 11.0%
Morphine710 nMBen Haddou et al. 2014 · 2 reports
- Assay
- CHO cells expressing human opioid receptor, [35S]GTPγS functional assay
- Shown value from
- Ben Haddou et al. 2014, Table 2
- Range
- 484–710 nM in 2 reports
- Error
- ± 23 SEM
- Emax
- 76.1 ± 2.0%
Values depend on the assay, species or conditions, and each is valid only for its own. 3 reports in all, 484–2185 nM.
Sources and values behind the range, same assay family Report Value Where Ben Haddou et al. 2014 710 nM Table 2 Toll et al. 1998 484 nM Table 7 Fentanyl2368 nMToll et al. 1998
- Assay
- human KOR-CHO cell membranes, [35S]GTPgammaS binding
- Shown value from
- Toll et al. 1998, Table 7
- Error
- ± 534 SD
- Emax
- 30.0 ± 4.0%
Methadone4943 nMToll et al. 1998
- Assay
- human KOR-CHO cell membranes, [35S]GTPgammaS binding
- Shown value from
- Toll et al. 1998, Table 7
- Error
- ± 400 SD
- Emax
- 25.0 ± 16.0%
Values are published numbers in nM per organism. Different assays, species and receptor preparations are not directly interchangeable, and a value does not establish clinical potency or safety.